Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:55:00 2026-10-02 EDT			5-day change	1st Jan Change
0.7000 ^EUR	-1.96%		-7.89%	-27.08%

09-25	Transgene provides update on its operations
09-08	Transgene Expands ProBioGen Partnership With Additional License	MT

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

5a83ed0.5nvd9u9Xhuzu5pOhXMPNgb8IzxN9nB6Jhmvy2DbmK6w.nhPpub4_q4uM1diUP4yLxNRjoX4Q_W668xOXnnC5R5y5PY-8mmTZmq-fyg~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
25-10-13	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
25-09-18	Transgene: analysts reiterate their recommendations after results
25-09-17	The day the Fed resumed its rate cuts
24-11-06	Transgene: Invest Securities remains Buy
24-10-15	Transgene: Invest Securities confirms its Buy recommendation
24-09-26	Transgene: Invest Securities confirms its opinion
23-06-06	Transgene: Invest Securities confirms its Buy rating
23-06-05	Transgene: Invest Securities reiterates its recommendation
23-03-22	Transgene: Invest Securities reduces its target
23-01-10	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+57.14%
	WUXI APPTEC CO., LTD.					+11.79%
	ARGENX SE					+27.75%
	LONZA GROUP AG					+21.67%
	REVOLUTION MEDICINES, INC.					+24.6%
	IQVIA HOLDINGS INC.					+11.82%
	BEONE MEDICINES AG					+21.07%
	CELLTRION, INC.					+46.63%
	WUXI BIOLOGICS (CAYMAN) INC.					+6.77%
	BIONTECH SE					+20.91%
	Average					+25.01%
	Weighted average by Cap.					+20.75%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7000EUR

Average target price

1.100EUR

Spread / Average Target

+57.14%

High Price Target

1.100EUR

Spread / Highest target

+57.14%

Low Price Target

1.100EUR

Spread / Lowest Target

+57.14%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
TNG Stock
Consensus Transgene

The best tools reserved for subscribers to boost the performance of your investments!